OxTalks will soon move to the new Halo platform and will become 'Oxford Events.' There will be a need for an OxTalks freeze. This was previously planned for Friday 14th November – a new date will be shared as soon as it is available (full details will be available on the Staff Gateway).
In the meantime, the OxTalks site will remain active and events will continue to be published.
If staff have any questions about the Oxford Events launch, please contact halo@digital.ox.ac.uk
Dr. Lladser is a Biochemist with a PhD in Biomedical Sciences from Universidad de Chile. He did his post-doctoral training at the Cancer Center of the Karolinska Institute, Stockholm, Sweden. Since 2010, Dr. Lladser directs the Laboratory of Immuno-oncology at Fundacion Ciencia & Vida and since 2019 he is Associate Professor at the Faculty of Medicine of Universidad San Sebastián. He is currently the Director of the Scientific and Technological Center of Excellence Ciencia & Vida (FB210008) from ANID. He is Principal Investigator of a FONDECYT Regular grant and co-investigator in several collaborative projects. His research focuses on unravelling the complex molecular and cellular networks that underlie effective T cell-mediated anti-tumour immunity by analysing human samples using high-dimensional transcriptomics and phenotypic analyses, as well as ex vivo functional assays and in vivo tumour models.
